Data Show Novartis/Gen-Probe Test Curbs HIV, HBV Transmission in South African Blood Supply
July 28, 2011
Data Show Novartis/Gen-Probe Test Curbs HIV, HBV Transmission in South African Blood Supply
A nucleic acid test marketed by Novartis Diagnostics and manufactured by Gen-Probe to screen individual blood donations for HIV and hepatitis have significantly increased the safety of the South African blood supply, according to recently presented data.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- NEJM Study of Gen-Probe Assay Backs Use of Triplex NAT in HBV Blood Screening
January 20, 2011 / PCR Insider - Q&A: New Novartis Dx President Discusses Nucleic Acid Testing, Blood Screening Business
March 15, 2012 / PCR Insider - PerkinElmer Buys Shanghai Haoyuan for Near-Term Blood Screening Play, Longer Term MDx Initiative
November 15, 2012 / PCR Insider - Dx Focus: Clinical and Regulatory PCR and Nucleic Acid Testing News
May 25, 2011 / PCR Insider - UCSD Study Finds that Nucleic Acid Testing Increases HIV Detection Yield
June 17, 2010 / PCR Insider